Schizophrenia Drugs Market Value Projected to Expand by 2029
The global schizophrenia drugs market is projected to exhibit a modest growth, at a CAGR of around 2.7%, during the forecast period. There has been a rise in stress management and mental health awareness initiatives across the globe. The need for these awareness programs is necessary as well due to the increasing level of mental disorders due to high stress in individuals. There are various organizations and educational institutions such as ALAS Pro Salud Mental and Stanford University that have taken immense steps to spread awareness programs. These programs are assisting individuals to notice behavior change and other stress-related symptoms in their daily lives on accounts of which the demand for schizophrenia drugs is expected to increase in the near future.
Mental health conditions have concerned various
organizations and one of them is WHO. According to WHO, the status of mental
health care varies widely from one country to another country. Many countries
already have policies to deliver services for mental health conditions in
primary care settings; however, they require system strengthening to achieve
integration. Further, by 2023, the WHO Special Initiative for Mental Health is
expected to increase treatment coverage for mental health conditions by ensuring
access to mental health care for 100 million more people over its 5-year plan.
This plan intends to contribute to the broader GPW13 targets for increasing
service coverage for severe mental health conditions to 50% and reducing
suicide mortality by 15%. This initiative is expected to offer growth to the
schizophrenia drugs market during the forecast period.
According to the World Economic Forum, the loss of
work output due to mental health is the highest across the globe. The mental
health contributes a huge 35% of total work loss due to increasing prevalence
of diseases across the globe. Further, according to WHO, more than 80% of
people with mental health conditions, including people with neurological and
substance use disorders, are without any form of quality, or affordable mental
healthcare? Hence the government is taking several initiatives taking mental
health in mind to overcome the economic losses that are a result of increased
stress levels. Thus, the increase in government-run initiatives to create
awareness related to stress management is anticipated to drive the market
growth in the near future.
Further, Stanford University launched an initiative
in 2018. The initiative's goal is to establish and maintain a forum to tackle
global mental health as a priority. This program would combine activities
focused on global mental health in healthcare, science, sports, and education
which is expected to immensely assist the growth of schizophrenia drugs market.
In addition, the new program would draw together the current activities of the
faculty and provide opportunities for new collaborations and initiatives. A
core component of the project is the use of IT resources to extend mental
health programs across the globe, taking advantage of Silicon Valley's
expertise.
To Request a Sample of our Report on Schizophrenia Drugs Market: https://www.omrglobal.com/request-sample/schizophrenia-drugs-market
Schizophrenia Drugs Market-Segmentation
By Type
- Second-Generation Antipsychotics
- Third-Generation Antipsychotics
- Others
By Treatment
- Oral
- Injectables
A full report of Schizophrenia Drugs Market is
available at: https://www.omrglobal.com/industry-reports/schizophrenia-drugs-market
Schizophrenia Drugs Market– Segment by Region
North
America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- AiCure, LLC
- Alkermes PLC
- Allergan PLC
- AstraZeneca PLC
- Biogen Inc.
- Catalent, Inc.
- Eli Lilly and Co.
- Lundbeck A/S
- Indivior PLC
- Johnson & Johnson Services, Inc.
- Lupin Ltd.
- Merck & Co., Inc.
- Minerva Neurosciences, Inc.
Reasons to Buy From us –
- We cover more than 15 major industries, further
segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your
questions before and after purchasing your report.
For more customized data, request for report
customization @ https://www.omrglobal.com/report-customization/schizophrenia-drugs-market
About Orion Market Research
Orion Market Research (OMR) is a market
research and consulting company known for its crisp and concise reports. The
company is equipped with an experienced team of analysts and consultants. OMR
offers quality syndicated research reports, customized research reports,
consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services
through another subsidiary Encanto
Technologies.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment